Mergers and acquisitions are becoming ever more popular, with activity up 24% in the first two months of this year — after already growing 23% in 2010. Here’s how your portfolio can benefit from this trend.
Co…
Johnson & Johnson has issued another recall, and this time, it’s not over a typo. The company’s Animas unit recalled five lots of leaking insulin cartridges whose use could lead to serious health problems. The 2-milliliter cart…
Most workers would worry about losing their jobs, let alone receiving a bonus, if they slacked off, but CEOs are held to a different standard. For example, despite several stumbles, GSK’s CEO got a nice bonus, and J&J’s CEO eve…
The company has landed a lucrative flu-vaccine contract with the U.S. government. It’s worth $97 million over the first three years, and it can be extended for an additional two years, for a total contract value of $179.1 milli…
The pharmaceutical industry is ready to fall off a cliff — a “patent cliff.” Over the next few years, some of the world’s most popular and lucrative medicines will go off patent, and generic competition will siphon an estimate…